ELI LILLY AND COMPANY COM NPV revenue breakdown overview

ELI LILLY AND COMPANY COM NPV revenue for the last year amounted to 28.73 B CHF, the most of which — 28.73 B CHF — came from its highest performing source at the moment, Human Pharmaceutical Products, the year earlier bringing 26.39 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought ELI LILLY AND COMPANY COM NPV 18.35 B CHF, and the year before that — 16.82 B CHF.